Skip to main content
Log in

Modified electroconvulsive therapy for the treatment of refractory schizophrenia-like psychosis associated with Huntington’s disease

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Walker FO (2007) Huntington’s disease. Lancet 369:218–228

    Article  PubMed  CAS  Google Scholar 

  2. Shiwach RS, Norbury CGA (1994) Controlled psychiatric study of individuals at risk for Huntington’s disease. Brit J Psychiatry 165:500–505

    Article  CAS  Google Scholar 

  3. Folstein SE, Chase GA, Wahl WE, McDonnell AM, Folstein MF (1987) Huntington’s disease in Maryland: clinical aspects of racial variation. Am J Hum Genet 41:168–179

    PubMed  CAS  Google Scholar 

  4. Hay DP, Hay L, Blackwell B, Spiro HR (1990) ECT and tardive dyskinesia. J Geriatr Psychiatry Neurol 3:106–109

    Article  PubMed  CAS  Google Scholar 

  5. Ward C, Stern GM, Pratt RT, McKenna P (1980) Electroconvulsive therapy in Parkinsonian patients with the “on–off” syndrome. J Neural Transm 49:133–135

    Article  PubMed  CAS  Google Scholar 

  6. Mendez MF (1994) Huntington’s disease: update and review of neuropsychiatric aspects. Int J Psychiatry Med 24:189–208

    Article  PubMed  CAS  Google Scholar 

  7. Evans DL, Pedersen CA, Tancer ME (1987) ECT in the treatment of organic psychosis in Huntington’s disease. Convuls Ther 3:145–150

    PubMed  Google Scholar 

  8. Caine ED, Shoulson I (1983) Psychiatric syndromes in Huntington’s disease. Am J Psychiatry 140:728–733

    PubMed  CAS  Google Scholar 

  9. Mughal MR, Baharani A, Chigurupati S, Son TG, Chen E, Yang P, Okun E, Arumugam T, Chan SL, Mattson MP (2011) Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice. Hum Mol Genet 20:659–669

    Article  PubMed  CAS  Google Scholar 

  10. Andrews TC, Brooks DJ (1998) Advances in the understanding of early Huntington’s disease using the functional imaging techniques of PET and SPET. Mol Med Today 4:532–539

    Article  PubMed  CAS  Google Scholar 

  11. van den Bogaard SJ, Dumas EM, Hart EP, Milles J, Reilmann R, Stout JC, Craufurd D, Gibbard CR, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA (2012) Magnetization transfer imaging in premanifest and manifest Huntington disease: a 2-year follow-up. Am J Neuroradiol [Epub ahead of print]

Download references

Conflicts of interest

The authors report no disclosures related to the current case presentation.

Ethical standard

This study has been approved by the appropriate ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinji Ono.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakano, T., Ono, S., Yamaguchi, J. et al. Modified electroconvulsive therapy for the treatment of refractory schizophrenia-like psychosis associated with Huntington’s disease. J Neurol 260, 312–314 (2013). https://doi.org/10.1007/s00415-012-6720-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-012-6720-2

Keywords

Navigation